|
English
|
正體中文
|
简体中文
|
2817371
|
|
???header.visitor??? :
27718270
???header.onlineuser??? :
716
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"parikh a"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立成功大學 |
2023 |
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer
|
Camidge, D.R.;Barlesi, F.;Goldman, J.W.;Morgensztern, D.;Heist, R.;Vokes, E.;Spira, A.;Angevin, E.;Su, W.-C.;Hong, D.S.;Strickler, J.H.;Motwani, Motwani M.;Dunbar, M.;Parikh, A.;Noon, E.;Blot, V.;Wu, J.;Kelly, Kelly K. |
臺大學術典藏 |
2022-09-15T01:08:44Z |
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
|
Italiano A.; Cassier P.A.; Chia-Chi Lin; Alanko T.; Peltola K.J.; Gazzah A.; Shiah H.-S.; Calvo E.; Cervantes A.; Roda D.; Tosi D.; Gao B.; Millward M.; Warburton L.; Tanner M.; Englert S.; Lambert S.; Parikh A.; Afar D.E.; Vosganian G.; Moreno V. |
臺大學術典藏 |
2020-05-25T07:35:09Z |
Safety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891
|
Powderly J; Cassier P.A; Cervantes A; Gao B; Gazzah A; Italiano A; Chia-Chi Lin; Luke J.J; Moreno V; Peltola K; Rasco D; Spira A.I; Tanner M.M.E; Tosi D; Afar D; Englert S; Parikh A; Reddy A; Vosganian G; Tolcher A.W. |
Showing items 1-3 of 3 (1 Page(s) Totally) 1 View [10|25|50] records per page
|